FIELD: medicine.
SUBSTANCE: rejuvenating effect is ensured by exposing high-molecular hyaluronic acid to gamma-radiation to preparing a stable low-molecular hyaluronic acid, which is used as a prescribed ingredient alongside with synthesised matrix peptide of specific amino acid sequence.
EFFECT: prescribed combination of low-molecular hyaluronic acid and matrix peptides of the developed cosmetic product enables achieving the pronounced aesthetic effect by a physiological mechanism of stimulation of developing proper hyaluronic acid in the skin.
2 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PERSONALISED COSMETIC AGENT | 2015 |
|
RU2608901C2 |
| COMPLEX COSMETIC AGENT | 2013 |
|
RU2524663C1 |
| MEANS FOR BIOLOGICAL REJUVENATION | 2016 |
|
RU2640188C1 |
| COMPLEX COSMETIC AGENT WITH REJUVENATING AND LIFTING EFFECT | 2010 |
|
RU2438648C1 |
| COMPLEX COSMETIC AGENT | 2012 |
|
RU2514003C1 |
| HYDROGEL WATER-SOLUBLE COMPOSITION BASED ON HYALURONIC ACID AND POLYVALENT METAL IONS AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2710074C1 |
| COMPLEX COSMETIC PRODUCT | 2016 |
|
RU2618428C1 |
| METHOD OF ANTI-AGING THERAPY | 2016 |
|
RU2610010C1 |
| MICRO-NANOSTRUCTURED BIOPLASTIC MATERIAL | 2012 |
|
RU2481127C1 |
| PHARMACEUTICAL COMPOSITION BASED ON HUMAN URINE AUTOBIOCOMPONENTS FOR TRANSDERMAL APPLICATION FOR THERAPEUTIC OR COSMETIC PURPOSES | 2020 |
|
RU2751037C1 |
